MedTrace Logo

Retrospective Chart Review of Treataprost Added to Antibiotic Treatment in Patients With Chronic Prostatitis

NCT05306314 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2022-04-01

No results posted yet for this study

Summary

Multicenter, Retrospectivecohort study in patients with Chronic Prostatitis, Chronic Bacterial Prostatitis (Category II) and Chronic Pelvic Pain Syndrome (Category IIIA, IIIB) and 140 patients without other significant comorbidities will be participated.

The aim of the study is to collect post-treatment data to evaluate inflammation, infection status and quality of life with standard antibiotic therapy with NSAID and added Treataprost effect.

Conditions

  • Quality of Life
  • Infection, Bacterial
  • PSA
  • Prostatitis

Interventions

DIETARY_SUPPLEMENT

TREATAPROST

oral administration before meals 30 minutes

Sponsors & Collaborators

  • Gama CRO Tıbbi İlaç Araştırma Org.Tic.Ltd.Şti

    collaborator UNKNOWN

  • GMG Grand Medical

    lead OTHER

Principal Investigators

  • Coşkun Kaya, Ass.Prof.Dr. · TR Ministry of Health Eskişehir City Hospital

  • Gökhan Temeltaş, Prof.Dr. · Manisa Celal Bayar University Hafsa Sultan Hospital

  • Cabir Alan, Prof. Dr. · Çanakkale Onsekiz Mart University

  • Taylan Oksay, Prof.Dr. · Süleyman Demirel University Faculty of Medicine

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-15
Primary Completion
2022-10-15
Completion
2023-10-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05306314 on ClinicalTrials.gov